Newsroom | 24140 results

BORDEAUX, France--(BUSINESS WIRE)--RebrAIn MDR Certification...

DUBLIN--(BUSINESS WIRE)--The "Implantable Medical Devices Market (2025 Edition): Analysis By Nature Type (Passive Implant, and Active Implant), By Product Type, By Material Type, By Application, By End-User, By Region, By Country: Market Insights and Forecast (2021-2031)" report has been added to ResearchAndMarkets.com's offering. The Global Implantable Medical Devices market showcased growth at a CAGR of 6.04% during 2021-2024. The market was valued at USD 92.89 Billion in 2024 which is expect...

TORONTO--(BUSINESS WIRE)--A new research report by the Canadian Centre for Policy Alternatives recommends Ontario make significant increases in hospital funding while phasing out costly for-profit staffing agencies and making investments in preventative health care. The report Hollowed Out: Ontario public hospitals and the rise of private staffing agencies shows a co-relation between the dramatic growth in agency usage and underfunding of public hospitals over the last decade. Between 2013-14 a...

MINEÁPOLIS--(BUSINESS WIRE)--HistoSonics, desarrollador del sistema de histotripsia Edison, anunció hoy que Blue Cross Blue Shield of Michigan (BCBSM) y Blue Care Network crearon una nueva póliza médica para la histotripsia del hígado. La póliza cubre la histotripsia no térmica realizada con el sistema de histotripsia Edison® para el tratamiento de tumores hepáticos primarios y metastásicos. A partir del 1 de febrero de 2025, la histotripsia es un procedimiento reembolsable para la destrucción...

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, développeur de l’Edison Histotripsy System, a annoncé aujourd’hui que Blue Cross Blue Shield of Michigan (BCBSM) et Blue Care Network ont créé une nouvelle politique médicale pour l’histotripsie du foie. Cette politique couvre l’histotripsie non thermique utilisant l’Edison® Histotripsy System pour le traitement des tumeurs hépatiques primaires et métastatiques. Depuis le 1er février 2025, l’histotripsie est une procédure remboursable pour la destructi...

LOS ANGELES--(BUSINESS WIRE)--As advances in early detection and treatment transform cancer into a chronic disease, City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, opens its largest outpatient facility among its network of 38 U.S. locations. Hope Plaza brings together cancer experts across specialties in one place, making care easier...

IRVINE, Calif.--(BUSINESS WIRE)--Immunis, Inc., a clinical-stage biotech developing multi-active biologics for age and disease-related immune dysregulation, was selected as one of the Top 40 Milestone 1 award winners for the $101 Million XPRIZE Healthspan Competition. Award-winning teams will each receive $250,000 to help support them through the next phase of the competition and all semi-finalists will be recognized during the XPRIZE Healthspan Award Ceremony and Investor Summit in NYC (May 12...

LEXINGTON, Mass.--(BUSINESS WIRE)--FUJIFILM Healthcare Americas Corporation, a leading provider of medical imaging and informatics solutions, announces that it has strengthened its partnership with the National Rural Health Association (NRHA) to help improve access to medical imaging in rural areas. Selected as a Platinum Partner by NRHA for a second 3-year term, Fujifilm is recognized for its leadership and dedication in providing products and services tailored for rural communities spanning M...

DALLAS--(BUSINESS WIRE)--Sonida Senior Living, Inc. (the “Company,” “Sonida,” “we,” “our,” or “us”) (NYSE: SNDA), a leading owner, operator and investor of senior housing communities, today announced its results for the first quarter ended March 31, 2025. “Sonida’s strong execution on its organic and inorganic growth strategy plan continued to bear meaningful results in the first quarter, driven by improvements in key metrics. Year-over-year same-store portfolio NOI margin expansion coupled wit...

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, the developer of the Edison Histotripsy System, today announced that Blue Cross Blue Shield of Michigan (BCBSM) and Blue Care Network have created a new medical policy for histotripsy of the liver. The policy covers non-thermal histotripsy using the Edison® Histotripsy System for the treatment of primary and metastatic liver tumors. As of February 1, 2025, histotripsy is a reimbursable procedure for the non-invasive mechanical destruction of liver tumo...